新闻稿 – 纽约州纽约市-2018年2月1日–Schhenzia Ross Ference Kesner律师事务所今天宣布，它已代表罗斯资本合伙人有限责任公司（Roth Capital Partners LLC）担任首席定位代理人和CIM /布鲁克莱恩证券公司（Brookline Securities） QBIO Med，Inc.（OTC.QBIO）的股票和权证系列。 QBIO是一家生物技术加速和开发公司，专注于获取和授权生命科学治疗产品。
QBIO以每股3.20美元的总价格向公众出售1,711,875股普通股和普通股认购权证所获得的总收益约550万美元。五年期权证的行权价格为每股3.20美元。普通股在OTCQB市场上以“QBIO”为代码进行交易。预计在2018年2月1日左右，以满足惯例成交条件为限。
Sichenzia Ross Ference Kesner LLP团队由合伙人Gregory Sichenzia和Jay Yamamoto领导。
Sichenzia Ross Ference Carmel LLP is a full service law firm with a nationally recognized corporate, securities and litigation practice that provides experienced representation in all matters involving the securities industry. In addition to handling routine to complex commercial matters, SRFC’s renowned litigation department specializes in defending companies and individuals against all types of securities cases, including class action lawsuits, shareholder derivative actions, and matters involving allegations of fraud, misrepresentation or other securities violations. The litigation team has also brought defamation lawsuits against companies and individuals related to market manipulation. Additionally, it represents individuals and companies in investigations by the Securities and Exchange Commission (SEC) and other regulatory bodies. The litigation team has a robust practice representing brokers and broker-dealers in arbitrations before the Financial Industry Regulatory Authority (FINRA). These arbitrations typically involve claims of unsuitability, churning, unauthorized trading and other allegations of broker misconduct. Finally, SRF has a burgeoning expungement practice, where it represents brokers seeking to have negative and harmful customer complaints removed from their industry records. The firm complements its core practice areas with an established commercial real estate and trusts and estates practice.
Visit SRFC's LinkedIn page
Visit SRFC's LinkedIn page
Latest posts by Sichenzia Ross Ference Carmel LLP (see all)
